| Literature DB >> 10636161 |
P K Pal1, D B Calne, S Calne, J K Tsui.
Abstract
The authors evaluated intraparotid injections of botulinum toxin A in reducing salivary secretions and drooling in nine patients with PD. There was a marked objective reduction in secretion, and two thirds of the patients had subjective improvement in drooling. No side effects were observed. The authors conclude that botulinum toxin A promises to be a simple and effective treatment for the common problem of drooling saliva in chronic neurologic disease.Entities:
Mesh：
Substances：
Year: 2000 PMID： 10636161 DOI： 10.1212/wnl.54.1.244
Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910